APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tenapanor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tenapanor Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchTenapanor Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Tenapanor Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Tenapanor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tenapanor Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tenapanor Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Tenapanor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tenapanor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tenapanor market include Kyowa Kirin, Fosun Pharma and Ardelyx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tenapanor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tenapanor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tenapanor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tenapanor market size, projected growth trends, production technologies, key applications, and end-use industries.

Tenapanor Segment by Company

Kyowa Kirin

Fosun Pharma

Ardelyx

Tenapanor Segment by Type

10mg per Tablet

20mg per Tablet

30mg per Tablet

50mg per Tablet

Tenapanor Segment by Application

Irritable Bowel Syndrome with Constipation

Hyperphosphatemia

Other

Tenapanor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tenapanor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tenapanor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tenapanor significant trends, drivers, influence factors in global and regions.

6. To analyze Tenapanor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenapanor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tenapanor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenapanor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tenapanor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tenapanor industry.

Chapter 3: Detailed analysis of Tenapanor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tenapanor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tenapanor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tenapanor Industry Trends Table 2. Tenapanor Industry Drivers Table 3. Tenapanor Industry Opportunities and Challenges Table 4. Tenapanor Industry Restraints Table 5. Global Tenapanor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tenapanor Revenue Share by Company (2021-2026) Table 7. Global Tenapanor Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Tenapanor Sales Volume Share by Company (2021-2026) Table 9. Global Tenapanor Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Tenapanor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tenapanor Key Company Manufacturing Base & Headquarters Table 12. Global Tenapanor Company, Product Type & Application Table 13. Global Tenapanor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tenapanor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg per Tablet Table 18. Significant Companies of 20mg per Tablet Table 19. Significant Companies of 30mg per Tablet Table 20. Significant Companies of 50mg per Tablet Table 21. Global Tenapanor Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Tenapanor Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Tenapanor Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Tenapanor Sales Volume Share by Type (2021-2026) Table 25. Global Tenapanor Sales Volume Share by Type (2027-2032) Table 26. Global Tenapanor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tenapanor Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Tenapanor Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Tenapanor Sales Value Share by Type (2021-2026) Table 30. Global Tenapanor Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Irritable Bowel Syndrome with Constipation Table 32. Significant Companies of Hyperphosphatemia Table 33. Significant Companies of Other Table 34. Global Tenapanor Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Tenapanor Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Tenapanor Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Tenapanor Sales Volume Share by Application (2021-2026) Table 38. Global Tenapanor Sales Volume Share by Application (2027-2032) Table 39. Global Tenapanor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Tenapanor Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Tenapanor Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Tenapanor Sales Value Share by Application (2021-2026) Table 43. Global Tenapanor Sales Value Share by Application (2027-2032) Table 44. Global Tenapanor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Tenapanor Sales by Region (2021-2026) & (K Units) Table 46. Global Tenapanor Sales Market Share by Region (2021-2026) Table 47. Global Tenapanor Sales by Region (2027-2032) & (K Units) Table 48. Global Tenapanor Sales Market Share by Region (2027-2032) Table 49. Global Tenapanor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Tenapanor Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Tenapanor Sales Value Share by Region (2021-2026) Table 52. Global Tenapanor Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Tenapanor Sales Value Share by Region (2027-2032) Table 54. Global Tenapanor Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Tenapanor Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Tenapanor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Tenapanor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Tenapanor Sales by Country (2021-2026) & (K Units) Table 59. Global Tenapanor Sales Market Share by Country (2021-2026) Table 60. Global Tenapanor Sales by Country (2027-2032) & (K Units) Table 61. Global Tenapanor Sales Market Share by Country (2027-2032) Table 62. Global Tenapanor Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Tenapanor Sales Value Market Share by Country (2021-2026) Table 64. Global Tenapanor Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Tenapanor Sales Value Market Share by Country (2027-2032) Table 66. Kyowa Kirin Company Information Table 67. Kyowa Kirin Business Overview Table 68. Kyowa Kirin Tenapanor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Kyowa Kirin Tenapanor Product Portfolio Table 70. Kyowa Kirin Recent Development Table 71. Fosun Pharma Company Information Table 72. Fosun Pharma Business Overview Table 73. Fosun Pharma Tenapanor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Fosun Pharma Tenapanor Product Portfolio Table 75. Fosun Pharma Recent Development Table 76. Ardelyx Company Information Table 77. Ardelyx Business Overview Table 78. Ardelyx Tenapanor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Ardelyx Tenapanor Product Portfolio Table 80. Ardelyx Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Tenapanor Distributors List Table 84. Tenapanor Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Tenapanor Product Image Figure 2. Global Tenapanor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tenapanor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tenapanor Sales (2021-2032) & (K Units) Figure 5. Global Tenapanor Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Tenapanor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg per Tablet Image Figure 10. 20mg per Tablet Image Figure 11. 30mg per Tablet Image Figure 12. 50mg per Tablet Image Figure 13. Global Tenapanor Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tenapanor Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Tenapanor Sales Volume Share by Type (2021-2032) Figure 16. Global Tenapanor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Tenapanor Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Tenapanor Sales Value Share by Type (2021-2032) Figure 19. Irritable Bowel Syndrome with Constipation Image Figure 20. Hyperphosphatemia Image Figure 21. Other Image Figure 22. Global Tenapanor Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Tenapanor Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Tenapanor Sales Volume Share by Application (2021-2032) Figure 25. Global Tenapanor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Tenapanor Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Tenapanor Sales Value Share by Application (2021-2032) Figure 28. Global Tenapanor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Tenapanor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Tenapanor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Tenapanor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Tenapanor Sales Value (2021-2032) & (US$ Million) Figure 33. North America Tenapanor Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Tenapanor Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Tenapanor Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Tenapanor Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Tenapanor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Tenapanor Sales Value (2021-2032) & (US$ Million) Figure 39. South America Tenapanor Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Tenapanor Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Tenapanor Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Tenapanor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Tenapanor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Tenapanor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Tenapanor Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Tenapanor Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg per Tablet
  • 20mg per Tablet
  • 30mg per Tablet
  • 50mg per Tablet
Applications
  • Irritable Bowel Syndrome with Constipation
  • Hyperphosphatemia
  • Other
Companies covered
  • Kyowa Kirin
  • Fosun Pharma
  • Ardelyx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tenapanor Sales Value (2021-2032)
  4. 1.2.2 Global Tenapanor Sales Volume (2021-2032)
  5. 1.2.3 Global Tenapanor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tenapanor Market Dynamics
  1. 2.1 Tenapanor Industry Trends
  2. 2.2 Tenapanor Industry Drivers
  3. 2.3 Tenapanor Industry Opportunities and Challenges
  4. 2.4 Tenapanor Industry Restraints
3 Tenapanor Market by Company
  1. 3.1 Global Tenapanor Company Revenue Ranking in 2025
  2. 3.2 Global Tenapanor Revenue by Company (2021-2026)
  3. 3.3 Global Tenapanor Sales Volume by Company (2021-2026)
  4. 3.4 Global Tenapanor Average Price by Company (2021-2026)
  5. 3.5 Global Tenapanor Company Ranking (2024-2026)
  6. 3.6 Global Tenapanor Company Manufacturing Base and Headquarters
  7. 3.7 Global Tenapanor Company Product Type and Application
  8. 3.8 Global Tenapanor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tenapanor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tenapanor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tenapanor Market by Type
  1. 4.1 Tenapanor Type Introduction
  2. 4.1.1 10mg per Tablet
  3. 4.1.2 20mg per Tablet
  4. 4.1.3 30mg per Tablet
  5. 4.1.4 50mg per Tablet
  6. 4.2 Global Tenapanor Sales Volume by Type
  7. 4.2.1 Global Tenapanor Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Tenapanor Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Tenapanor Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Tenapanor Sales Value by Type
  11. 4.3.1 Global Tenapanor Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Tenapanor Sales Value by Type (2021-2032)
  13. 4.3.3 Global Tenapanor Sales Value Share by Type (2021-2032)
5 Tenapanor Market by Application
  1. 5.1 Tenapanor Application Introduction
  2. 5.1.1 Irritable Bowel Syndrome with Constipation
  3. 5.1.2 Hyperphosphatemia
  4. 5.1.3 Other
  5. 5.2 Global Tenapanor Sales Volume by Application
  6. 5.2.1 Global Tenapanor Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tenapanor Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Tenapanor Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Tenapanor Sales Value by Application
  10. 5.3.1 Global Tenapanor Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tenapanor Sales Value by Application (2021-2032)
  12. 5.3.3 Global Tenapanor Sales Value Share by Application (2021-2032)
6 Tenapanor Regional Sales and Value Analysis
  1. 6.1 Global Tenapanor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tenapanor Sales by Region (2021-2032)
  3. 6.2.1 Global Tenapanor Sales by Region: 2021-2026
  4. 6.2.2 Global Tenapanor Sales by Region (2027-2032)
  5. 6.3 Global Tenapanor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tenapanor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tenapanor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tenapanor Sales Value by Region (2027-2032)
  9. 6.5 Global Tenapanor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tenapanor Sales Value (2021-2032)
  12. 6.6.2 North America Tenapanor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tenapanor Sales Value (2021-2032)
  15. 6.7.2 Europe Tenapanor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tenapanor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tenapanor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tenapanor Sales Value (2021-2032)
  21. 6.9.2 South America Tenapanor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tenapanor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tenapanor Sales Value Share by Country, 2025 VS 2032
7 Tenapanor Country-level Sales and Value Analysis
  1. 7.1 Global Tenapanor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tenapanor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tenapanor Sales by Country (2021-2032)
  4. 7.3.1 Global Tenapanor Sales by Country (2021-2026)
  5. 7.3.2 Global Tenapanor Sales by Country (2027-2032)
  6. 7.4 Global Tenapanor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tenapanor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tenapanor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tenapanor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tenapanor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tenapanor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tenapanor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tenapanor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tenapanor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tenapanor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tenapanor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tenapanor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tenapanor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tenapanor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tenapanor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tenapanor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tenapanor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tenapanor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tenapanor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tenapanor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tenapanor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tenapanor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tenapanor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tenapanor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tenapanor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tenapanor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tenapanor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tenapanor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tenapanor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tenapanor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tenapanor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tenapanor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tenapanor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tenapanor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tenapanor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tenapanor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tenapanor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tenapanor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tenapanor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tenapanor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tenapanor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tenapanor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tenapanor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tenapanor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tenapanor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tenapanor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tenapanor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tenapanor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tenapanor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tenapanor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tenapanor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tenapanor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tenapanor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tenapanor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tenapanor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tenapanor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tenapanor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tenapanor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tenapanor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tenapanor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tenapanor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tenapanor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tenapanor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tenapanor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tenapanor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tenapanor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tenapanor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tenapanor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tenapanor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tenapanor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tenapanor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tenapanor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tenapanor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tenapanor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tenapanor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tenapanor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tenapanor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tenapanor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tenapanor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tenapanor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tenapanor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tenapanor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tenapanor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tenapanor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tenapanor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tenapanor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tenapanor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kyowa Kirin
  2. 8.1.1 Kyowa Kirin Company Information
  3. 8.1.2 Kyowa Kirin Business Overview
  4. 8.1.3 Kyowa Kirin Tenapanor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kyowa Kirin Tenapanor Product Portfolio
  6. 8.1.5 Kyowa Kirin Recent Developments
  7. 8.2 Fosun Pharma
  8. 8.2.1 Fosun Pharma Company Information
  9. 8.2.2 Fosun Pharma Business Overview
  10. 8.2.3 Fosun Pharma Tenapanor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fosun Pharma Tenapanor Product Portfolio
  12. 8.2.5 Fosun Pharma Recent Developments
  13. 8.3 Ardelyx
  14. 8.3.1 Ardelyx Company Information
  15. 8.3.2 Ardelyx Business Overview
  16. 8.3.3 Ardelyx Tenapanor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ardelyx Tenapanor Product Portfolio
  18. 8.3.5 Ardelyx Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tenapanor Value Chain Analysis
  2. 9.1.1 Tenapanor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tenapanor Sales Mode & Process
  6. 9.2 Tenapanor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tenapanor Distributors
  9. 9.2.3 Tenapanor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst